- Report
- October 2023
- 240 Pages
Global
€4620EUR$4,795USD£3,974GBP
- Report
- October 2023
- 83 Pages
United States
From €3373EUR$3,500USD£2,901GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4770EUR$4,950USD£4,103GBP
- Report
- March 2018
- 161 Pages
Global
From €1325EUR$1,375USD£1,140GBP
€2650EUR$2,750USD£2,279GBP
- Report
- February 2023
- 100 Pages
Global
From €5733EUR$5,950USD£4,932GBP
- Report
- November 2022
- 90 Pages
Global
From €5733EUR$5,950USD£4,932GBP
- Report
- February 2021
- 120 Pages
Global
From €5733EUR$5,950USD£4,932GBP
- Report
- March 2022
- 300 Pages
Global
From €3854EUR$4,000USD£3,315GBP
- Report
- September 2019
- 76 Pages
South Africa
From €2024EUR$2,100USD£1,741GBP
€2891EUR$3,000USD£2,487GBP
- Report
- August 2022
- 111 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- June 2022
- 120 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- September 2022
- 30 Pages
Global
From €2650EUR$2,750USD£2,279GBP
- Drug Pipelines
- March 2020
- 100 Pages
Global
From €3132EUR$3,250USD£2,694GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- January 2022
- 200 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- January 2022
- 200 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- January 2022
- 200 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates.
Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more